Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Valent

Showing results (51-60 of 316) with videos related to

Pageof 32
Sort By:
Journal of Clinical Pathology|February 1, 2003
Chymase expressing bone marrow mast cells in mastocytosis and myelodysplastic syndromes: an immunohistochemical and morphometric studyH-P Horny, A Greschniok, J-H Jordan, et al.
The Histochemical Journal|April 5, 2002
Fetuin in human bone marrow: detection in foetal tissue and patients with mastocytosisK M Dziegielewska, H P Horny, P Valent, et al.
Human Pathology|February 24, 1999
Mast cells are augmented in deep vein thrombosis and express a profibrinolytic phenotypeH C Bankl, K Grossschmidt, B Pikula, et al.
International Archives of Allergy and Immunology|November 1, 1994
Inhibition of stem cell factor dependent formation of human mast cells by interleukin-3 and interleukin-4C Sillaber, W R Sperr, H Agis, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 1, 1991
Recombinant human interleukin 3 induces proliferation of inflammatory cells and keratinocytes in vivoB Volc-Platzer, P Valent, T Radaszkiewicz, et al.
Haematologica|December 7, 2007
Aggressive systemic mastocytosis with sarcoma-like growth in the skeleton, leukemic progression, and partial loss of mast cell differentiation antigensM T Krauth, M Födinger, L Rebuzzi, et al.
European Journal of Clinical Investigation|November 22, 2008
Treatment responses to cladribine and dasatinib in rapidly progressing aggressive mastocytosisK J Aichberger, W R Sperr, K V Gleixner, et al.
Leukemia|March 1, 1988
T cell receptor alpha mRNA transcription in T-lymphoblastic transformation of chronic myelocytic leukemiaP Valent, C R Bartram, T Radaszkiewicz, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 29, 2009
Midostaurin (PKC412) inhibits immunoglobulin E-dependent activation and mediator release in human blood basophils and mast cellsM-T Krauth, I Mirkina, H Herrmann, et al.
Pharmacology|March 23, 2007
CCI-779 plus cisplatin is highly effective against human melanoma in a SCID mouse xenotranplantation modelC Thallinger, W Poeppl, B Pratscher, et al.
Pageof 32

Showing results (51-60 of 316) with videos related to

Sort By:
Pageof 32
Journal of Clinical Pathology|February 1, 2003
Chymase expressing bone marrow mast cells in mastocytosis and myelodysplastic syndromes: an immunohistochemical and morphometric studyH-P Horny, A Greschniok, J-H Jordan, et al.
The Histochemical Journal|April 5, 2002
Fetuin in human bone marrow: detection in foetal tissue and patients with mastocytosisK M Dziegielewska, H P Horny, P Valent, et al.
Human Pathology|February 24, 1999
Mast cells are augmented in deep vein thrombosis and express a profibrinolytic phenotypeH C Bankl, K Grossschmidt, B Pikula, et al.
International Archives of Allergy and Immunology|November 1, 1994
Inhibition of stem cell factor dependent formation of human mast cells by interleukin-3 and interleukin-4C Sillaber, W R Sperr, H Agis, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 1, 1991
Recombinant human interleukin 3 induces proliferation of inflammatory cells and keratinocytes in vivoB Volc-Platzer, P Valent, T Radaszkiewicz, et al.
Haematologica|December 7, 2007
Aggressive systemic mastocytosis with sarcoma-like growth in the skeleton, leukemic progression, and partial loss of mast cell differentiation antigensM T Krauth, M Födinger, L Rebuzzi, et al.
European Journal of Clinical Investigation|November 22, 2008
Treatment responses to cladribine and dasatinib in rapidly progressing aggressive mastocytosisK J Aichberger, W R Sperr, K V Gleixner, et al.
Leukemia|March 1, 1988
T cell receptor alpha mRNA transcription in T-lymphoblastic transformation of chronic myelocytic leukemiaP Valent, C R Bartram, T Radaszkiewicz, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 29, 2009
Midostaurin (PKC412) inhibits immunoglobulin E-dependent activation and mediator release in human blood basophils and mast cellsM-T Krauth, I Mirkina, H Herrmann, et al.
Pharmacology|March 23, 2007
CCI-779 plus cisplatin is highly effective against human melanoma in a SCID mouse xenotranplantation modelC Thallinger, W Poeppl, B Pratscher, et al.
Pageof 32